{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T16:19:07Z","timestamp":1785860347365,"version":"3.56.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2022,8,12]],"date-time":"2022-08-12T00:00:00Z","timestamp":1660262400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,8,12]],"date-time":"2022-08-12T00:00:00Z","timestamp":1660262400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100000163","name":"Pediatric Oncology Group of Ontario","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000163","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1007\/s00520-022-07287-w","type":"journal-article","created":{"date-parts":[[2022,8,12]],"date-time":"2022-08-12T02:02:28Z","timestamp":1660269748000},"page":"8855-8869","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Interventions for the prevention of acute phase chemotherapy-induced nausea and vomiting in adult and pediatric patients: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"30","author":[{"given":"Priya","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula D.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora","family":"Wahib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Cabral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arden","family":"Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"Devine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark T.","family":"Holdsworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eloise","family":"Neumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Orsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Spinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Thackray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"van de Wetering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Woods","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lillian","family":"Sung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7699-1061","authenticated-orcid":false,"given":"L. Lee","family":"Dupuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,12]]},"reference":[{"key":"7287_CR1","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.critrevonc.2015.12.001","volume":"99","author":"S Sommariva","year":"2016","unstructured":"Sommariva S, Pongiglione B, Tarricone R (2016) Impact of chemotherapy-induced nausea and vomiting on health-related quality of life and resource utilization: a systematic review. Crit Rev Oncol Hematol 99:13\u201336","journal-title":"Crit Rev Oncol Hematol"},{"issue":"4","key":"7287_CR2","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1007\/s00520-016-3520-8","volume":"25","author":"AR Peoples","year":"2017","unstructured":"Peoples AR, Roscoe JA, Block RC et al (2017) Nausea and disturbed sleep as predictors of cancer-related fatigue in breast cancer patients: a multicenter NCORP study. Support Care Cancer 25(4):1271\u20131278","journal-title":"Support Care Cancer"},{"issue":"10","key":"7287_CR3","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1007\/s00520-005-0803-x","volume":"13","author":"N Neymark","year":"2005","unstructured":"Neymark N, Crott R (2005) Impact of emesis on clinical and economic outcomes of cancer therapy with highly emetogenic chemotherapy regimens: a retrospective analysis of three clinical trials. Support Care Cancer 13(10):812\u2013818","journal-title":"Support Care Cancer"},{"issue":"15","key":"7287_CR4","doi-asserted-by":"publisher","first-page":"e24133","DOI":"10.1200\/JCO.2020.38.15_suppl.e24133","volume":"38","author":"LS Schwartzberg","year":"2020","unstructured":"Schwartzberg LS, Navari RM, Ruddy KJ et al (2020) Work loss and activity impairment due to duration of nausea and vomiting in patients with breast cancer receiving CINV prophylaxis. J Clin Oncol 38(15):e24133\u2013e24133","journal-title":"J Clin Oncol"},{"issue":"9","key":"7287_CR5","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1038\/bmt.2017.112","volume":"52","author":"J Flank","year":"2017","unstructured":"Flank J, Sparavalo J, Vol H et al (2017) The burden of chemotherapy-induced nausea and vomiting in children receiving hematopoietic stem cell transplantation conditioning: a prospective study. Bone Marrow Transplant 52(9):1294\u20131299","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"7287_CR6","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1200\/JOP.2015.004234","volume":"11","author":"CB Hendricks","year":"2015","unstructured":"Hendricks CB (2015) Improving adherence with oral antiemetic agents in patients with breast cancer receiving chemotherapy. J Oncol Pract 11(3):216\u2013218","journal-title":"J Oncol Pract"},{"issue":"1","key":"7287_CR7","doi-asserted-by":"publisher","first-page":"e29329","DOI":"10.1002\/pbc.29329","volume":"69","author":"N Tang","year":"2022","unstructured":"Tang N, Kovacevic A, Zupanec S et al (2022) Perceptions of parents of pediatric patients with acute lymphoblastic leukemia on oral chemotherapy administration: a qualitative analysis. Pediatr Blood Cancer 69(1):e29329","journal-title":"Pediatr Blood Cancer"},{"issue":"8","key":"7287_CR8","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1093\/annonc\/mds021","volume":"23","author":"M Aapro","year":"2012","unstructured":"Aapro M, Molassiotis A, Dicato M et al (2012) The effect of guideline-consistent antiemetic therapy on chemotherapy-induced nausea and vomiting (CINV): the Pan European Emesis Registry (PEER). Ann Oncol 23(8):1986\u20131992","journal-title":"Ann Oncol"},{"issue":"1","key":"7287_CR9","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1200\/JOP.2012.000816","volume":"10","author":"JW Gilmore","year":"2014","unstructured":"Gilmore JW, Peacock NW, Gu A et al (2014) Antiemetic guideline consistency and incidence of chemotherapy-induced nausea and vomiting in US community oncology practice: INSPIRE study. J Oncol Practice 10(1):68\u201374","journal-title":"J Oncol Practice"},{"issue":"6","key":"7287_CR10","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1007\/s11096-016-0393-3","volume":"38","author":"N Abunahlah","year":"2016","unstructured":"Abunahlah N, Sancar M, Dane F et al (2016) Impact of adherence to antiemetic guidelines on the incidence of chemotherapy-induced nausea and vomiting and quality of life. Int J Clin Pharm 38(6):1464\u20131476","journal-title":"Int J Clin Pharm"},{"issue":"7","key":"7287_CR11","doi-asserted-by":"publisher","first-page":"3439","DOI":"10.1007\/s00520-020-05935-7","volume":"29","author":"R Chow","year":"2021","unstructured":"Chow R, Herrstedt J, Aapro M et al (2021) Olanzapine for the prophylaxis and rescue of chemotherapy-induced nausea and vomiting: a systematic review, meta-analysis, cumulative meta-analysis and fragility assessment of the literature. Support Care Cancer 29(7):3439\u20133459","journal-title":"Support Care Cancer"},{"issue":"11","key":"7287_CR12","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1007\/s00228-021-03157-2","volume":"77","author":"YC Hsu","year":"2021","unstructured":"Hsu YC, Chen CY, Tam KW et al (2021) Effectiveness of palonosetron versus granisetron in preventing chemotherapy-induced nausea and vomiting: a systematic review and meta-analysis. Eur J Clin Pharmacol 77(11):1597\u20131609","journal-title":"Eur J Clin Pharmacol"},{"issue":"4","key":"7287_CR13","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.7314\/APJCP.2016.17.4.1661","volume":"17","author":"DM Yuan","year":"2016","unstructured":"Yuan DM, Li Q, Zhang Q et al (2016) Efficacy and safety of neurokinin-1 receptor antagonists for prevention of chemotherapy-induced nausea and vomiting: systematic review and meta-analysis of randomized controlled trials. Asian Pac J Cancer Prev 17(4):1661\u20131675","journal-title":"Asian Pac J Cancer Prev"},{"issue":"5","key":"7287_CR14","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1007\/s00520-019-05280-4","volume":"28","author":"R Chow","year":"2020","unstructured":"Chow R, Valdez C, Chow N et al (2020) Oral cannabinoid for the prophylaxis of chemotherapy-induced nausea and vomiting-a systematic review and meta-analysis. Support Care Cancer 28(5):2095\u20132103","journal-title":"Support Care Cancer"},{"key":"7287_CR15","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71","journal-title":"BMJ"},{"issue":"1","key":"7287_CR16","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2307\/2529310","volume":"33","author":"JR Landis","year":"1977","unstructured":"Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33(1):159\u2013174","journal-title":"Biometrics"},{"issue":"24","key":"7287_CR17","doi-asserted-by":"publisher","first-page":"2782","DOI":"10.1200\/JCO.20.01296","volume":"38","author":"PJ Hesketh","year":"2020","unstructured":"Hesketh PJ, Kris MG, Basch E et al (2020) Antiemetics: ASCO Guideline Update. J Clin Oncol 38(24):2782\u20132797","journal-title":"J Clin Oncol"},{"issue":"5","key":"7287_CR18","doi-asserted-by":"publisher","first-page":"e27646","DOI":"10.1002\/pbc.27646","volume":"66","author":"E Paw Cho Sing","year":"2019","unstructured":"Paw Cho Sing E, Robinson PD, Flank J et al (2019) Classification of the acute emetogenicity of chemotherapy in pediatric patients: a clinical practice guideline. Pediatr Blood Cancer 66(5):e27646","journal-title":"Pediatr Blood Cancer"},{"key":"7287_CR19","unstructured":"Higgins JPT, Green S (2011) Editors Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011]. The Cochrane Collaboration. Available from: www.cochrane-handbook.org. Accessed\u00a0 20 Jun 2020"},{"key":"7287_CR20","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration: RevMan (computer program). Version 5.4. https:\/\/training.cochrane.org\/online-learning\/coresoftware-cochrane-reviews\/revman\/revman-5-download. Accessed 1 Dec 2021"},{"issue":"7","key":"7287_CR21","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1093\/annonc\/mdu110","volume":"25","author":"PJ Hesketh","year":"2014","unstructured":"Hesketh PJ, Rossi G, Rizzi G et al (2014) Efficacy and safety of NEPA, an oral combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy: a randomized dose-ranging pivotal study. Ann Oncol 25(7):1340\u20131346","journal-title":"Ann Oncol"},{"issue":"6","key":"7287_CR22","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1093\/oxfordjournals.annonc.a058556","volume":"4","author":"KS Buser","year":"1993","unstructured":"Buser KS, Joss RA, Piquet D et al (1993) Oral ondansetron in the prophylaxis of nausea and vomiting induced by cyclophosphamide, methotrexate and 5-fluorouracil (CMF) in women with breast cancer Results of a prospective, randomized, double-blind, placebo-controlled study. Ann Oncol 4(6):475\u20139","journal-title":"Ann Oncol"},{"issue":"9","key":"7287_CR23","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1200\/JCO.1995.13.9.2417","volume":"13","author":"Anonymous","year":"1995","unstructured":"Anonymous (1995) Persistence of efficacy of three antiemetic regimens and prognostic factors in patients undergoing moderately emetogenic chemotherapy Italian Group for Antiemetic Research. J Clin Oncol 13(9):2417\u201326","journal-title":"J Clin Oncol"},{"issue":"1","key":"7287_CR24","doi-asserted-by":"publisher","first-page":"90","DOI":"10.4143\/crt.2017.577","volume":"51","author":"SY Jeon","year":"2019","unstructured":"Jeon SY, Han HS, Bae WK et al (2019) A randomized, double-blind, placebo-controlled study of the safety and efficacy of olanzapine for the prevention of chemotherapy-induced nausea and vomiting in patients receiving moderately emetogenic chemotherapy: results of the Korean South West Oncology Group (KSWOG) study. Cancer Res Treat 51(1):90\u201397","journal-title":"Cancer Res Treat"},{"issue":"2","key":"7287_CR25","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1080\/003655998750014459","volume":"32","author":"S Schelin","year":"1998","unstructured":"Schelin S, Palmqvist E, Madsen M et al (1998) Antiemetic efficacy of prednisolone: a placebo-controlled trial in patients with advanced prostatic cancer treated with estramustine phosphate. Scand J Urol Nephrol 32(2):102\u2013106","journal-title":"Scand J Urol Nephrol"},{"issue":"7","key":"7287_CR26","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1002\/pbc.24508","volume":"60","author":"LL Dupuis","year":"2013","unstructured":"Dupuis LL, Boodhan S, Holdsworth M et al (2013) Guideline for the prevention of acute nausea and vomiting due to antineoplastic medication in pediatric cancer patients. Pediatr Blood Cancer 60(7):1073\u20131082","journal-title":"Pediatr Blood Cancer"},{"key":"7287_CR27","doi-asserted-by":"crossref","unstructured":"Patel P, Robinson PD, Thackray J et al (2017) Guideline for the prevention of acute chemotherapy-induced nausea and vomiting in pediatric cancer patients: a focused update. Pediatr Blood Cancer\u00a064(10)","DOI":"10.1002\/pbc.26542"},{"issue":"22","key":"7287_CR28","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1200\/JCO.20.00134","volume":"38","author":"LL Dupuis","year":"2020","unstructured":"Dupuis LL, Tomlinson GA, Pong A et al (2020) Factors associated with chemotherapy-induced vomiting control in pediatric patients receiving moderately or highly emetogenic chemotherapy: a pooled analysis. J Clin Oncol 38(22):2499\u20132509","journal-title":"J Clin Oncol"},{"key":"7287_CR29","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.ctcp.2019.01.004","volume":"35","author":"MR Keene","year":"2019","unstructured":"Keene MR, Heslop IM, Sabesan SS et al (2019) Complementary and alternative medicine use in cancer: a systematic review. Complement Ther Clin Pract 35:33\u201347","journal-title":"Complement Ther Clin Pract"},{"issue":"6","key":"7287_CR30","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1200\/JGO.2016.005587","volume":"3","author":"C Diorio","year":"2017","unstructured":"Diorio C, Lam CG, Ladas EJ et al (2017) Global use of traditional and complementary medicine in childhood cancer: a systematic review. J Glob Oncol 3(6):791\u2013800","journal-title":"J Glob Oncol"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-022-07287-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-022-07287-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-022-07287-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T10:35:36Z","timestamp":1667471736000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-022-07287-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,12]]},"references-count":30,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["7287"],"URL":"https:\/\/doi.org\/10.1007\/s00520-022-07287-w","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,12]]},"assertion":[{"value":"8 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Financial interests: LLD has received grants from Heron Therapeutics for work outside of this clinical practice guideline. AO owns Pfizer stock.No other author has relevant financial or non-financial interests to disclose.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}